Cambrex announces $425m acquisition of American CDMO Halo Pharma

Cambrex Corporation, a leading manufacturer of small molecules and generic Active Pharmaceutical Ingredients (APIs), has announced a strategic acquisition of Halo Pharma for $425 million. ... Read More